More good news came  from Exelixis (EXEL). It was expected by many but not by those who …

Exelixis collaborator, Daiichi Sankyo, Receives Regulatory Approval for MINNEBRO™ (Esaxerenone) Tablets for Hypertension in Japan Exelixis …

Earlier this month the U.S. Food and Drug Administration (FDA) granted Fast Track Designation for CTX001 for …

Rhythm Pharmaceuticals, Inc. (RYTM) is a biopharmaceutical company focused on the development and commercialization of therapeutics for …

The NEW Prohost Portfolio Small Important Changes We are making some very small but important changes …

Gilead Sciences (GILD) and Scholar Rock Holding Corporation (SRRK) announced entering into a strategic collaboration to discover and develop …

Agenus (AGEN) announced recently that it entered into an immuno-oncology (I-O) partnership with Gilead Sciences (GILD). …

During the departed week, outstanding advancements and improvements in various clinical disciplines filled the media. What’s …

The Chinese National Medical Products Administration (NMPA) has approved Gilead’s (GILD) HIV combination product Descovy®.  In China, Descovy is …

The Week in Review #35 Politics and the Market The market tumbled today as Theresa May, …